Ophthalmology · Mooresville, NC
NPI
1376807214
Since 2012
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
185 Joe Knox Ave
Mooresville, NC, 28117
Phone (704) 658-2321
Groups this clinician bills Medicare through
Medicare paid, 2024
$194K
2,551 services
Medicare patients, 2024
672
Average age 76
Drug cost, 2024
$1.3M
7,326 prescriptions
Company payments, 2025
$1,196
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randall N Stein was code 99214 (office e&m - established), 848 times for 450 patients. In total Randall N Stein billed 2,551 services in 31 codes, and Medicare paid $194K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 848 | 450 | $81.30 | $69K |
| 92014 Ophthalmological E&M | Office | 422 | 373 | $77.35 | $33K |
| 92083 Vision, Hearing, and Speech Services | Office | 390 | 351 | $43.04 | $17K |
| 92133 Computerized Ophthalmic Imaging | Office | 350 | 342 | $23.10 | $8,083 |
| 92020 Ophthalmological E&M | Office | 76 | 76 | $19.03 | $1,446 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 72 | 72 | $12.34 | $888 |
| 76514 Ultrasound - Nonspecific | Office | 63 | 63 | $7.70 | $485 |
| 92004 Ophthalmological E&M | Office | 47 | 47 | $89.71 | $4,216 |
| 66984 Cataract Surgery | Facility | 42 | 25 | $317.58 | $13K |
| 92136 Ultrasound - Nonspecific | Office | 41 | 37 | $31.18 | $1,278 |
| 92134 Computerized Ophthalmic Imaging | Office | 41 | 38 | $27.38 | $1,123 |
| 66821 Cataract Surgery | Office | 21 | 16 | $235.34 | $4,942 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 20 | 14 | $180.37 | $3,607 |
| 65820 Fluid Flow and Drainage of Eye (Any Method) | Facility | 16 | 11 | $604.85 | $9,678 |
| 92082 Vision, Hearing, and Speech Services | Office | 14 | 14 | $24.44 | $342 |
By year: 2022 $221K for 2,517 services; 2023 $205K for 2,456 services; 2024 $194K for 2,551 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randall N Stein prescribed most often to Medicare patients was Latanoprost, with 1,431 prescriptions and refills. In total Randall N Stein wrote 7,326 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,431 | 3,041 | 370 | $14K |
| Timolol Maleate Generic | 956 | 1,834 | 231 | $9,477 |
| Brimonidine Tartrate Generic | 652 | 1,367 | 185 | $32K |
| Dorzolamide Hcl Generic | 567 | 1,138 | 147 | $9,534 |
| Lumigan Bimatoprost | 556 | 1,142 | 177 | $313K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 464 | 934 | 120 | $6,327 |
| Rhopressa Netarsudil Mesylate | 397 | 661 | 119 | $202K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 397 | 623 | 92 | $222K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 256 | 457 | 73 | $41K |
| Lotemax Sm Loteprednol Etabonate | 207 | 240 | 103 | $56K |
| Ofloxacin Generic | 199 | 206 | 154 | $1,997 |
| Alphagan P Brimonidine Tartrate | 197 | 344 | 61 | $79K |
| Prednisolone Acetate Generic | 167 | 194 | 104 | $6,824 |
| Combigan Brimonidine Tartrate/Timolol | 163 | 313 | 50 | $71K |
| Simbrinza Brinzolamide/Brimonidine Tart | 110 | 178 | 30 | $31K |
Brand drugs: 2,855 claims; generic drugs: 4,471 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randall N Stein $1,196 ($1,196 in general payments such as food, travel and fees) from 12 companies. The largest payer was Alcon Vision LLC with $520.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.